These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 27533043)

  • 21. In vivo hyperoxia induces hypoxia-inducible factor-1α overexpression in LNCaP tumors without affecting the tumor growth rate.
    Terraneo L; Virgili E; Caretti A; Bianciardi P; Samaja M
    Int J Biochem Cell Biol; 2014 Jun; 51():65-74. PubMed ID: 24704415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Silibinin inhibits aberrant lipid metabolism, proliferation and emergence of androgen-independence in prostate cancer cells via primarily targeting the sterol response element binding protein 1.
    Nambiar DK; Deep G; Singh RP; Agarwal C; Agarwal R
    Oncotarget; 2014 Oct; 5(20):10017-33. PubMed ID: 25294820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel inhibitor of hypoxia-inducible factor-1α P3155 also modulates PI3K pathway and inhibits growth of prostate cancer cells.
    Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Sonawane V; Rathos MJ; Kumar S; Joshi KS
    BMC Cancer; 2011 Aug; 11():338. PubMed ID: 21819554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1α and signaling in LNCaP prostate cancer cells.
    Park KY; Lee HJ; Jeong SJ; Lee HJ; Kim HS; Kim SH; Lim S; Kim HC; Lü J; Kim SH
    Biol Pharm Bull; 2010; 33(11):1835-40. PubMed ID: 21048308
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
    Kim DH; Hossain MA; Kim MY; Kim JA; Yoon JH; Suh HS; Kim GY; Choi YH; Chung HY; Kim ND
    Int J Oncol; 2013 Dec; 43(6):1915-24. PubMed ID: 24100602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
    Singh RP; Gu M; Agarwal R
    Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage-specific inhibitory effects and associated mechanisms of silibinin on tumor progression and metastasis in transgenic adenocarcinoma of the mouse prostate model.
    Raina K; Rajamanickam S; Singh RP; Deep G; Chittezhath M; Agarwal R
    Cancer Res; 2008 Aug; 68(16):6822-30. PubMed ID: 18701508
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tanshinone IIA inhibits β-catenin/VEGF-mediated angiogenesis by targeting TGF-β1 in normoxic and HIF-1α in hypoxic microenvironments in human colorectal cancer.
    Sui H; Zhao J; Zhou L; Wen H; Deng W; Li C; Ji Q; Liu X; Feng Y; Chai N; Zhang Q; Cai J; Li Q
    Cancer Lett; 2017 Sep; 403():86-97. PubMed ID: 28602978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The marine-derived HIF-1α inhibitor, Yardenone 2, reduces prostate cancer cell proliferation by targeting HIF-1 target genes.
    Peng S; Guo Y; Irondelle M; Mazzu A; Kahi M; Ferreira Montenegro P; Bost F; Mazure NM
    Cell Mol Biol Lett; 2024 Jul; 29(1):101. PubMed ID: 38978018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction.
    Kim KH; Kim D; Park JY; Jung HJ; Cho YH; Kim HK; Han J; Choi KY; Kwon HJ
    J Mol Med (Berl); 2015 May; 93(5):499-509. PubMed ID: 25471482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathways.
    Mi C; Ma J; Wang KS; Zuo HX; Wang Z; Li MY; Piao LX; Xu GH; Li X; Quan ZS; Jin X
    J Ethnopharmacol; 2017 May; 203():27-38. PubMed ID: 28341244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PKM2 and HIF-1α regulation in prostate cancer cell lines.
    Hasan D; Gamen E; Abu Tarboush N; Ismail Y; Pak O; Azab B
    PLoS One; 2018; 13(9):e0203745. PubMed ID: 30216369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway.
    Kami Reddy KR; Dasari C; Vandavasi S; Natani S; Supriya B; Jadav SS; Sai Ram N; Kumar JM; Ummanni R
    ACS Comb Sci; 2019 Apr; 21(4):241-256. PubMed ID: 30673277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR/HIF-1α/VEGF pathway.
    Peng W; Zhang S; Zhang Z; Xu P; Mao D; Huang S; Chen B; Zhang C; Zhang S
    J Ethnopharmacol; 2018 Oct; 224():140-148. PubMed ID: 29852266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-cancer effect of pristimerin by inhibition of HIF-1α involves the SPHK-1 pathway in hypoxic prostate cancer cells.
    Lee SO; Kim JS; Lee MS; Lee HJ
    BMC Cancer; 2016 Aug; 16(1):701. PubMed ID: 27581969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Apoptotic Effect of HIF-1α Inhibition Combined with Glucose plus Insulin Treatment on Gastric Cancer under Hypoxic Conditions.
    Tanaka T; Kitajima Y; Miyake S; Yanagihara K; Hara H; Nishijima-Matsunobu A; Baba K; Shida M; Wakiyama K; Nakamura J; Noshiro H
    PLoS One; 2015; 10(9):e0137257. PubMed ID: 26339797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
    Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
    J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diacetoxyscirpenol as a new anticancer agent to target hypoxia-inducible factor 1.
    Choi YJ; Shin HW; Chun YS; Leutou AS; Son BW; Park JW
    Oncotarget; 2016 Sep; 7(38):62107-62122. PubMed ID: 27613833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Over-expression of hypoxia-inducible factor 1 alpha increases angiogenesis of LNCaP cells in vivo].
    Han YL; He DL; Luo Y; Cheng HP; Zhu GF
    Zhonghua Nan Ke Xue; 2008 May; 14(5):439-44. PubMed ID: 18572865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.